HCPLive® peer-to-peer panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's cancer care professionals.
Diagnosis and Treatment of Immune-Mediated Kidney DiseasesMarch 9th 2023
In this program, renal experts will discuss management of immune-mediated kidney diseases. They will discuss challenges in diagnosis of immunoglobulin A neuropathy (IgAN) and C3 glomerulopathy (C3G) and emerging treatment options for them.
Personalizing Treatment Selection in Atopic DermatitisDecember 20th 2022
Expert dermatologists discuss 3 patient case scenarios and their approach to finding the best treatment for each patient type. They discuss data, pros and cons of use of various classes of treatments, approaches to monitoring the disease, and changing treatment based on patient and disease characteristics.
Expert Perspectives on Advances in the Management of Major Depressive DisorderDecember 16th 2022
Experts in psychiatry focus on treatment options for major depressive disorder (MDD). The discussion centers on data with newer mechanisms of action, new and emerging treatment options, and management of MDD in specific patient populations and how new treatments are aiming to fulfill unmet needs in MDD.
Advances and Unmet Needs in the Management of Plaque Psoriasis – Expert Advanced Practice Provider PerspectivesDecember 9th 2022
Advanced practice providers in dermatology discuss the treatment landscape for the management of plaque psoriasis. They review available and emerging treatment options, highlighting recent approvals and long-term safety and efficacy data.
Advances in Targeted Therapy Selection in Rheumatoid ArthritisDecember 7th 2022
Rheumatology specialists discuss challenges in the management of rheumatoid arthritis (RA), and how the trial-and-error approach to treatment selection and continued use of ineffective treatments impacts quality of life in RA. The panel discusses tools available to guide treatment selection and how personalization of care can improve treatment outcomes.
Advances & Unmet Needs in the Management of Plaque Psoriasis – Expert Advanced Practice Provider PerspectivesOctober 28th 2022
In this upcoming HCPLive program, experts review available and emerging treatment options for the management of plaque psoriasis, highlighting recent approvals and long-term safety and efficacy data.
Recent Approvals in Vaccination Against SARS-CoV-2 and the Omicron SubvariantsOctober 24th 2022
Expert health professionals provide key insights on recently approved SARS-CoV-2 booster shots highlighting current recommendations and optimizing patient communication and education on vaccination options.
Evolving Strategies for Cholesterol Management and Atherosclerotic Cardiovascular Disease Risk ReductionOctober 14th 2022
Experts in cardiology discuss the management of hypercholesterolemia and atherosclerotic cardiovascular diseases (ASCVD), the importance of achieving LDL-C lowering goals, and treatment of hypercholesterolemia in patients who are statin-intolerant.
Expert Perspectives on Managing Polyvascular Disease and Coronary Artery DiseaseApril 29th 2022
A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.
JAK inhibitors for the Management of Atopic Dermatitis (AD)April 27th 2022
Linda Stein Gold, MD; Raj J. Chovatiya, MD, PhD; Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, share their approaches to optimizing the treatment of atopic dermatitis with a focus on the utilization of topical and oral JAK inhibitors.